A clear Tesamorelin research vial on a coloured plaster ledge, with botanicals beside it

About this compound

Tesamorelin is a synthetic analogue of the complete 44-residue human GHRH sequence, modified with a trans-3-hexenoyl group at the N-terminus.

Studied in

  • GH/IGF-1 axis
  • Adipose distribution models
  • Endocrine signalling

Compound identity

CompoundTesamorelin
CAS number901758-09-6
Molecular formulaC221H366N72O67S
Molecular weight5,135.9 Da

Specifications

  • Purity method: HPLC
  • Appearance: Lyophilized powder
  • Solubility: Reconstitute per protocol; see Supplies for diluents.
  • We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.

Endocrine

VERDICT

Tesamorelin

Stabilised GHRH analog, studied in metabolic-endocrine research.

What the research targets

Studied as a stabilised GHRH analog in GH-axis research, including adipose-tissue distribution models.

Supply formats

Single units ship from stock. Cases are back-ordered against the same single-unit price.

Stick is newly released — available alongside the vial on every compound.

Single unit

Sample quantity — one unit.

  • 10 mgVial

    PS-9789916-10-MG

    On verified account
  • Skinni Stick™ 10 mgSkinni Stick™New

    Single-compound Skinni Stick™. Supplied to verified accounts only.

    PS-9789916-PEN-10-MG

    On verified account

Case — back-order

Ten of one size, at 10× volume pricing.

  • Case · 10 × 10 mg

    Back-order — 15% off the single-unit price.

    PS-9789916-C10-10-MG

    On verified account
  • Case · 10 × Skinni Stick™ 10 mgNew

    Back-order — 15% off the single-unit price.

    PS-9789916-C10-PEN-10-MG

    On verified account

One-time verification of professional or institutional affiliation. No payment is taken on this site.

Research use only

This compound is supplied exclusively for laboratory research by qualified professionals and institutions. It is not a drug, dietary supplement, or cosmetic, and is not for human or veterinary use. We publish no dosing, administration, or human-use guidance of any kind, and nothing here should be read as a claim about an effect in people.

From the research library

Cited summaries of the published work behind Tesamorelin — what was studied, in which model, and what was measured.

All articles

More in Endocrine